ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Session » Miscellaneous Rheumatic and Inflammatory Diseases

Meeting: 2014 ACR/ARHP Annual Meeting

Abstract Number: 832
NOD2-Associated Autoinflammatory Disease: The Largest Cohort Study
Abstract Number: 833
Canakinumab Use in Patients with Cryopyrin-Associated Periodic Syndrome: Interim Safety and Efficacy Results from Beta-Confident Registry
Abstract Number: 834
Interleukin-18 (IL-18) As a Biomarker for Diagnosis and Evaluation of Disease Activity in Patients with Adult Onset Still’s Disease and Systemic Onset Juvenile Idiopathic Arthritis
Abstract Number: 835
Relapsing Polychondritis Can be Characterized By 3 Different Clinical Phenotypes: Analysis of a Series of 142 Patients
Abstract Number: 836
Categorical Change in 6MWD in Patients with Connective Tissue Disease Associated Pulmonary Arterial Hypertension Receiving Ambrisentan over 3-Years
Abstract Number: 837
Progressive Multifocal Leukoencephalopathy Associated with Biologic Therapy in Rheumatic Diseases: Strengthening Association with Rituximab
Abstract Number: 1225
Clinical Presentation and Cytokine Production Abnormalities in a Cohort of Patients Carrying NLRP12 GENE Variants
Abstract Number: 1226
Studying Patients with Autoinflammatory Diseases: The Past, Present, and a Perspective for the Future
Abstract Number: 1227
Cryopyrinopathy with a Myeloid-Specific NLRP3 Mutation
Abstract Number: 1228
Involvement of the IFN-Õ Pathway in a Patient with Candle Syndrome Carrying  a Novel Variant of PSMB8 Gene
Abstract Number: 1229
Is NOD2-Associated Autoinflammatory Disease Remotely Related to Familial Mediterranean Fever or Continuum of It?
Abstract Number: 1230
Efficacy of Interleukin-1 Targeting Drugs in Familial Mediterranean Fever Patients
Abstract Number: 1231
Evidence Based Recommendations for Genetic Diagnosis of Familial Mediterranean Fever
Abstract Number: 1232
Canakinumab Therapy in Patients with Familial Mediterranean Fever
Abstract Number: 1233
Tocilizumab (TCZ) in the Treatment of AA Amyloidosis in Patients with Familial Mediterranean Fever
Abstract Number: 1234
Periodic Fever Syndromes in an Academic Medical Center
Abstract Number: 1235
Recovery of Renal Function after Corticosteroid Therapy for IgG4-Related Kidney Disease
Abstract Number: 1236
IgG4 Immunostaining Is Common but Not Specific in Orbitbal Inflammatory Diseases
Abstract Number: 1237
Retroperitoneal Fibrosis and IgG4 Disease: Response to Immunosuppressive Therapy – a Single Centre Retrospective Study
Abstract Number: 1238
Proportion of Peripheral Plasmacytoid Dendritic Cells and Plasmablasts Reflects Disease Activity in IgG4-related Disease
Abstract Number: 1239
Is Lymphocytic Sialadenitis IgG4-Related?
Abstract Number: 1240
Efficacy of Anakinra in Refractory Adult-Onset Still´s Disease: Multicenter Study of 41 Patients
Abstract Number: 1241
Efficacy of Tocilizumab Therapy in Korean Patients with Adults Onset Still’s Disease: Multicenter Retrospective Study of 20 Cases
Abstract Number: 1242
Switching Biologic Agents in Refractory Adult-Onset Still’s Disease: Efficacy and Safety in a Cohort of 20 Patients at a Single Referral Center
Abstract Number: 1243
Macrophage Activation Syndrome Complicating Adult Onset Still’s Disease – Single Center Experience and Literature Review
Abstract Number: 1244
The Prevalence of Malignancy in Adult-Onset Still’s Disease
Abstract Number: 1245
Long Term Outcome of Infliximab in Severe and Refractory Systemic Sarcoidosis: Report of 16 Cases
Abstract Number: 1246
Assessment of Protective Factors of Bone Mineral Density in a New Orleans Sarcoidosis Population
Abstract Number: 1247
The Prevalence of Sacroiliitis and   Spondyloarthritis in Patients with Sarcoidosis
Abstract Number: 1248
Serologic and Clinical Overlap Between Sarcoidosis and the Rheumatic Autoimmume Diseases
Abstract Number: 1249
Efficacy of Tocilizumab in Patients with Uveitis Refractory to Other Biologic Drugs: A Multicenter Study on 31 Cases
Abstract Number: 1250
Golimumab As an Alternative Therapy in Patients with Uveitis Refractory to Other Anti-TNFα Drugs. Multicenter Study of 29 Cases
Abstract Number: 1251
Efficacy of Certolizumab in Patients with Refractory Uveitis to Other Biologic Therapy. Study of 7 Cases
Abstract Number: 1252
Intravenous Methylprednisolone Pulse Therapy in Severe Inflammatory Eye Disease. a Multicenter Study
Abstract Number: 1253
Anakinra – a Promising New Therapy for Idiopathic Recurrent Pericarditis
Abstract Number: 1254
Anakinra for the Management of Resistant Idiopathic Recurrent Pericarditis in Adults
Abstract Number: 2186
Clinical and Immunologic Correlates in Cocaine Users with Serum Anti-Neutrophil Cytoplasmic Antibodies
Abstract Number: 2187
Revisiting RS3PE after Twenty Five Years: A Systematic Review of 250 Cases
Abstract Number: 2188
Incidence and Mortality of Relapsing Polychondritis in the United Kingdom: A Population-Based Cohort Study
Abstract Number: 2189
Multicentric Reticulohistiocytosis- Case Series from a Tertiary Care Center
Abstract Number: 2190
Features of Interstitial Lung Disease Associated with Connective Tissue Disease in a Spanish Southwest Cohort
Abstract Number: 2191
Intravenous Sodium Thiosulfate for Treatment of Refractory Calcinosis in Rheumatic Disease
Abstract Number: 2192
Successful Therapy with Intravenous Sodium Thiosulfate for Adult Dermatomyositis Associated Calcinosis
Abstract Number: 2193
Prevalence of Raynaud’s Phenomenon and Nailfold Capillaroscopic Abnormalities in Fabry’s Disease: A Cross-Sectional Study
Abstract Number: 2194
Blue Digit Syndrome: The Rheumatologist’s Perspective
Abstract Number: 2195
Eculizumab Treatment of Malignant Atrophic Papulosis (Köhlmeier-Degos Disease): World Experience to Date
Abstract Number: 2196
Treprostinil Use in Malignant Atrophic Papulosis (Köhlmeier-Degos Disease): Review of Worldwide Experience to Date
Abstract Number: 2197
Malignant Atrophic Papulosis (MAP) Complicating Connective Tissue Diseases (CTDs)
Abstract Number: 2198
The Aromatase Inhibitor Induced Musculoskeletal Syndrome: Is There a Potential Role of Osteoporosis Therapy and Menopause Timing?
Abstract Number: 2199
Intravenous Immunoglobulin Therapy for Secondary Hemophagocytic Lymphohistiocytosis : A Retrospective Study of 46 Patients
Abstract Number: 2200
Elevated Serum Ferritin Levels in Adult Inpatients As a Predictor of in-Hospital Mortality and Association with Macrophage Activation Syndrome
Abstract Number: 2201
Haematological Complications in Rheumatic Diseases: Not Only Lymphomas
Abstract Number: 2202
Pilot Study of Tocilizumab in Patients with Erdheim-Chester Disease
Abstract Number: 2203
Adalimumab Therapy Improves Insulin Sensitivity in Non-Diabetic Psoriatic Patients: A 6-Month Prospective Study
Abstract Number: 2204
New Onset Vitiligo Under Biological Agents: A Case Series
Abstract Number: 2205
Management of Asymptomatic Coccidioidomycosis in Patients with Rheumatic Disease
Abstract Number: 2206
The Incidence of Zoster in Patients with Cutaneous Lupus Erythematosus and Dermatomyositis Is Increased Compared to the Average U.S. Population
Abstract Number: 2207
Decreased Bone Mineral Density in Patients with Ehler-Danlos Syndrome
Abstract Number: 2208
Ovarian Reserve Alterations in Premenopausal Women with Rheumatoid Arthritis, Behcet’s Disease and Spondyloarthritis – Impact on Anti-Muellerian Hormone Levels
Abstract Number: 2209
Novel Biomarkers of Extracellular Matrix Remodeling in Inflammatory Bowel Disease: Different Patterns of Gut Injury in UC and CD

« View all sessions from this meeting

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences